Luis García-Ortiz Selected Research

Osteoprotegerin

5/2012

Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luis García-Ortiz Research Topics

Disease

10	Hypertension (High Blood Pressure) 01/2023 - 01/2008
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2021 - 09/2009
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2022 - 01/2018
2	Obesity 01/2022 - 03/2014
2	Insulin Resistance 12/2019 - 01/2013
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 07/2015 - 12/2010
2	Necrosis 05/2012 - 09/2009
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Virus Diseases (Viral Diseases) 12/2021
1	Abdominal Obesity 10/2021
1	Pathologic Constriction (Stenosis) 09/2020
1	Heart Failure 03/2016
1	Atrial Fibrillation 01/2016
1	Hemorrhage 01/2016
1	Atherosclerosis 01/2016
1	Fibrosis (Cirrhosis) 07/2015
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 07/2015
1	Weight Loss (Weight Reduction) 07/2015
1	Chronic Disease (Chronic Diseases) 01/2014
1	Myocardial Infarction 01/2012
1	Hypertensive Retinopathy 12/2010
1	Hyperlipidemias (Hyperlipidemia) 03/2010
1	Diabetes Mellitus 03/2010
1	Liver Diseases (Liver Disease) 09/2009
1	Hypoxia (Hypoxemia) 09/2009

Drug/Important Bio-Agent (IBA)

5	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 01/2008
3	LipidsIBA 01/2022 - 01/2008
3	Indicators and Reagents (Reagents)IBA 12/2019 - 12/2010
3	AlbuminsIBA 07/2015 - 03/2010
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2019 - 12/2010
2	CreatinineIBA 07/2015 - 03/2010
2	CytokinesIBA 05/2012 - 09/2009
2	EnzymesIBA 12/2010 - 09/2009
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2023
1	Retinaldehyde (Retinal)IBA 02/2022
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2022
1	Messenger RNA (mRNA)IBA 12/2021
1	Triglycerides (Triacylglycerol)IBA 10/2021
1	HDL CholesterolIBA 10/2021
1	Blood Glucose (Blood Sugar)IBA 10/2021
1	CalciumIBA 09/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2016
1	AntioxidantsIBA 01/2016
1	Superoxide DismutaseIBA 01/2016
1	TabletsIBA 01/2016
1	ChemokinesIBA 07/2015
1	FatsIBA 07/2015
1	Biomarkers (Surrogate Marker)IBA 07/2015
1	Fibrinogen (Factor I)FDA Link 01/2014
1	OsteoprotegerinIBA 05/2012
1	EndoglinIBA 12/2010
1	ImmunosorbentsIBA 12/2010
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 03/2010
1	TransferasesIBA 09/2009
1	Interleukin-6 (Interleukin 6)IBA 09/2009
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2009
1	DiureticsIBA 01/2009
1	ras ProteinsIBA 01/2009
1	Angiotensin Receptor AntagonistsIBA 01/2009
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2009

Therapy/Procedure

2	Mediterranean Diet 01/2019 - 07/2015
2	Therapeutics 03/2016 - 01/2016
1	Drug Therapy (Chemotherapy) 03/2016
1	Patient Readmission 01/2012